Hologic, Inc. (Nasdaq: HOLX) announced today that the U.S. Food and Drug Administration (FDA) has granted an expanded clearance for Cynosure’s non-invasive body contouring product, SculpSure, to treat the back and inner and outer thighs. The SculpSure treatment is already FDA-cleared for treatment of the abdomen and love handles (flanks).…
Source: PSP
Read more: Hologic Receives Expanded FDA 510(k) Clearance to Market Cynosure’s SculpSure® for Non-Invasive Body Contouring (Lipolysis) of Back, Inner and Outer Thighs